Telix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening Agent
1. FDA approved Telix's Gozellix for prostate cancer PET testing. 2. Gozellix has a longer shelf life than existing products. 3. Shares of TLX increased 6% after FDA announcement. 4. Telix shares rose over 20% since starting U.S. trading. 5. CEO calls FDA approval a significant win for patients.